Portfolio

Vessi Medical

Cryotherapy for treatment of superficial bladder cancer

Now Funding

Technology Development

Business Development

Revenue

Exited

Founded

2015

CEO
Eyal Kochavi
UN SDGs
3 13
Contact Us
email email
Follow Us
linkedin
Investors
The Trendlines Group ; the Israel Innovation Authority, Agriline (CBG)

About

Vessi Medical takes a new approach in the treatment of superficial bladder cancer. The Company uses surface cryotherapy, a treatment that utilizes extreme cold, to freeze and destroy abnormal tissue. Its minimally invasive solution for non-muscle-invasive bladder cancer (NMIBC) provides an office-based therapeutic alternative to surgery.

Currently, surface cryotherapy is used extensively in many applications, and it has been known to be highly effective in destroying surface lesions.

The Vessi Medical system consists of a standalone console and a disposable catheter that is inserted into the bladder similar to existing intravesical (inside the bladder) techniques.

Market Need

The market seeks an effective treatment for superficial bladder cancer that offers reduced recurrence rates, reduced side effects, improved patient outcomes, and lower health care costs.

Skip to content